A method for the synthesis of key intermediates of loteranar catalyzed by a chiral phase transfer catalyst
By using a chiral phase transfer catalyst to catalyze the synthesis of key intermediates of loteranal, the problems of expensive catalysts and large losses in chiral resolution in existing technologies have been solved, realizing an efficient and economical route for the synthesis of loteranal.
Patent Information
- Application Number
- CN202311333498.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-10-16
- Publication Date
- 2026-11-10
- Estimated Expiration
- 2043-10-16
AI Technical Summary
Existing routes for the synthesis of loteranane suffer from problems such as expensive catalysts, large quantities required, use of precious metal catalysts, and significant losses due to chiral resolution, resulting in high synthesis costs and low efficiency.
A chiral phase transfer catalyst was used to catalyze the synthesis of key intermediates of loteranar. This one-pot method efficiently synthesized the key raw materials, avoiding the use of expensive raw materials. A Grignard reagent strategy was adopted, using AlCl3 and AcOCl as reaction reagents. By combining different solvents and basic reagents, phase transfer catalysts cat.1-7 were developed to achieve efficient synthesis.
This reduces synthesis costs, increases ee value and yield, and enables the efficient and economical synthesis of lotelanar key intermediates.
Smart Images

Figure CN117447459B_ABST
Abstract
Description
Technical Field
[0001] This invention belongs to the field of pharmaceutical synthesis, specifically relating to a method for the synthesis of a key intermediate of lotilaner using a chiral phase transfer catalyst. Background Technology
[0002] The patent for Lotilaner was filed by Novartis on December 17, 2009, with international publication number WO2010070068.
[0003] Currently, apart from the routes disclosed by Novartis' animal health division (reference routes 1, WO2022016490 and WO2022020585) and one route disclosed by Medisin Biopharmaceuticals Chengdu Co., Ltd. (reference route 2, CN112457267A), no other routes have been disclosed.
[0004] Reference routes 1 (WO2022016490 and WO2022020585):
[0005]
[0006] Reference Route 2: (CN112457267A)
[0007]
[0008] In reference route 1, a catalyst is required: The ee value is 80%. The compound is then recrystallized to obtain a product with 96.5% yield of the S configuration, 3.5% yield of the R configuration, and an ee value of 93%. This route involves relatively expensive starting materials and requires a large amount of chiral catalyst, approximately 10 mol%. In the synthetic route of Reference Route 2, a noble metal palladium catalyst and a chiral resolution reagent are needed, but chiral resolution methods often result in significant losses.
[0009] Given the shortcomings of the existing publicly available routes, it is necessary to develop more technologically effective process routes. Summary of the Invention
[0010] To address the aforementioned problems, this invention designs and develops a chiral phase transfer catalyst and a method for the catalytic synthesis of key intermediates of Lotilaner.
[0011] In a first aspect, the present invention provides a method for preparing compound S2, wherein compound S2 is prepared by reacting compound S1.
[0012]
[0013] The reaction reagents are AlCl3 and AcOCl.
[0014] The solution is dichloromethane.
[0015] On the other hand, a method for preparing compound S4 is provided, wherein compound S4 is prepared by reacting compound S3.
[0016]
[0017] R1 can be Cl, Br, F, I or H, with Cl being the most preferred.
[0018] In the Grignard reaction, dibromoethane is required; other reagents can be Mg / i PrMgCl-LiCl, wherein the reaction solvent is THF.
[0019] Furthermore, compound S4 was reacted to prepare compound S5.
[0020]
[0021] The reaction solvent is THF.
[0022] The definition of R1 is the same as above.
[0023] The above-mentioned compounds S5 and S2 were further reacted to prepare compound S6.
[0024]
[0025] The reaction reagent is a base such as Et3N.
[0026] The solvent can be MTBE.
[0027] The reaction reagent can be SOCl2.
[0028] The definition of R1 is the same as above.
[0029] Furthermore, compound S6 was reacted to prepare compound S7.
[0030]
[0031] The reaction reagent is HO-NH2.
[0032] Furthermore, compound S7 was reacted to prepare compound S8.
[0033]
[0034] Secondly, the present invention provides a method for preparing the catalyst, and the following are the reaction equations for synthesizing the phase transfer catalysts cat.1-7.
[0035] Specifically, it is prepared by reacting arylbenzyl bromide with a quinine compound.
[0036] The reaction solvent may be acetone.
[0037] In the preparation of compound S7, a preferred embodiment of the present invention is as follows:
[0038]
[0039] In the preparation of compound S7, the most preferred embodiment of the present invention is as follows:
[0040]
[0041] This invention synthesized phase transfer catalysts Cat.1-7 for the catalytic synthesis of S7. However, under the same conditions (5 mol% phase transfer catalyst), it was found that the ee value of the product S7 synthesized by Cat.7 as a catalyst (66.8% ee) was lower than that of Cat.5 (82.4% ee) and Cat.6 (76.3% ee). Currently, Cat.5 and Cat.6 have not been reported for the synthesis of S7 and similar structural products. Moreover, in the entire synthetic route, this invention does not directly use the expensive key raw material S5 (3,4,5-trichlorophenyltrifluoroethyl ketone). Instead, it adopts a strategy of in-situ synthesis of Grignard reagents from the simplest and cheapest raw materials, and synthesizes the key raw material S5 in a one-pot high-yield manner (steps 2 and 3). This greatly saves synthesis costs and makes the entire synthetic route more efficient and practical. Detailed Implementation
[0042] To further understand the present invention, the following detailed description, in conjunction with embodiments, illustrates the invention. It should be understood that these embodiments are merely for further detailing the features of the invention and are not intended to limit the scope of the invention or the scope of the claims.
[0043] Example 1:
[0044] At room temperature and under N2 protection, acetyl chloride (42.8 mL, 600 mmol) and 320 mL of dichloromethane were added to a dry flask; in a smaller vial, S1 (35.4 g, 200 mmol) was added and dissolved in 120 mL of dichloromethane; the S1 dichloromethane solution was added to the flask and mixed with the acetyl chloride; under N2, solid AlCl3 (40.0 g, 300 mmol) was slowly added; the reaction was stirred overnight at room temperature, and after about 18 hours, the solution turned... The solution is purple. To stop the reaction, quench it with ice water (or ice cubes) in an ice bath. A large amount of gas is released, and the solution changes from purple to green (possibly a darker color). After no more bubbles are released, quench it with a sodium bicarbonate solution at 0°C. A large amount of bubbles are released until the solution turns yellow and the number of bubbles significantly decreases (adding too much sodium bicarbonate will produce a yellow precipitate, which can be removed by filtration with diatomaceous earth). Extract the system with dichloromethane (100 mL three times), combine the organic phases, dry with anhydrous sodium sulfate, and then evaporate the organic phase to dryness.
[0045] The product was evaporated to dryness to obtain a brown or dark green product S2 (21.3 g, 97%) with high purity, which did not require further purification.
[0046] Example 2:
[0047] At 25℃ (room temperature), cut magnesium strips (2.92g, 120mmol) washed with dilute hydrochloric acid into small pieces and add them to a 1L three-necked round-bottom flask. Add 170mL of ultra-dry THF and 0.25mL of dibromoethane and stir. In a constant-pressure dropping funnel, add 80mL of S3 dissolved in ultra-dry THF (26.04g, 100mol) and set aside. Add a small amount of S3 solution dropwise and heat the solution in the flask with a hot air gun until it just boils (bubbles are generated on the surface of the magnesium strip). Then gradually add the remaining S3 solution dropwise, keeping the reaction solution at a gentle boil and generating bubbles. If the reaction weakens, it needs to be heated with a hot air gun. After all the S3 solution has been added, reflux at 85℃ for 4-5 hours. Monitor the reaction with GC. The reaction is complete when S3 is fully converted, which takes about 3-5 hours. Prepare Grignard reagent S4 for later use (Grignard reagent S4 can also be prepared by exchanging S3 with isopropyl magnesium chloride and lithium chloride reagent).
[0048] Example 3:
[0049] At 25℃ (room temperature), under N2 protection, 100 mL of ultra-dry THF was added and stirred. Trifluoroacetic anhydride (19.5 mL, 140 mmol) was added and stirred for 1 h. Under ice bath conditions, the prepared Grignard reagent was added to the trifluoroacetic anhydride solution using a long needle. Then, the mixture was stirred at room temperature for 12 h. Under stirring conditions, 4 mol / L HCl was added to quench the reaction until no bubbles were generated. The mixture was separated and extracted three times with EA. All organic phases were then combined, washed once with saturated sodium chloride solution (100 mL), and dried over anhydrous sodium sulfate. The organic phases were then evaporated to dryness and dried under vacuum to obtain a brownish-yellow oily crude S5 product. No purification was required for the next reaction.
[0050] Example 4:
[0051] At room temperature, S2 (21.9 g, 100 mmol) was added to a 500 mL three-necked round-bottom flask. Under N2 protection, 120 mL of MTBE was added and stirred to dissolve the S2. Under N2 protection, crude S5 dissolved in 100 mL of MTBE was added, followed by triethylamine (42.2 g, 417 mmol). The mixture was refluxed at 70 °C for 2 h. TLC monitoring showed complete conversion of S5. The mixture was then cooled to room temperature for later use. Under ice bath conditions, SOCl2 (51.5 mL, 140 mmol) was slowly added dropwise. The mixture was refluxed at 40 °C for 2 h and stirred at room temperature for 16 h. Under stirring, saturated sodium bicarbonate aqueous solution was added to quench the reaction until no bubbles were generated. The mixture was separated and extracted three times with MTBE. All organic phases were then combined, washed once with saturated sodium chloride solution (100 mL), and dried over anhydrous sodium sulfate. A suitable amount of silica gel was added and vortexed to form a powder. The powder was then loaded onto a dry column (n-hexane:ethyl acetate = 40:1) to obtain crude product S6. 31.2g, yield: 65.2%.
[0052] Example 5:
[0053] Under N2 protection, at room temperature, 26.7 g of S6 (approximately 55.8 mmol) and the corresponding cat.1-7 (0.05 eq. 2.8 mmol) were dissolved in 250 mL of dichloromethane (7 parallel reactions), and stirred at 30 °C for 1 h; 10.31 g of potassium hydroxide (3.3 eq. 184.1 mmol) was dissolved in 18.4 mL of water (10 M), with strong exothermic reaction, and cooled to room temperature; the reaction solution described in step 1 above, stirred at 30 °C for 1 h (or more), was placed at -20 °C and stirred under N2 protection, and then 13.3 mL of hydroxylamine aqueous solution (4.0 eq. 223.2 mmol) was added separately. A 50% (w%) solution of dichloromethane and potassium hydroxide aqueous solution was added dropwise to the reaction mixture using a syringe, and the mixture was stirred at -20°C for 16 hours. The reaction system was then brought to room temperature, and 100 mL of dichloromethane and 200 mL of saturated saline solution were added. The mixture was separated, and the aqueous phase was extracted three times with dichloromethane (100 mL each time). All dichloromethane was combined, and the mixture was washed three times with saturated saline solution (200 mL each time). The solution was dried over anhydrous sodium sulfate to obtain approximately 600 mL of crude product S7 in dichloromethane. The crude product S7 dichloromethane solution was added to silica gel and evaporated to dryness until a fine, flowing liquid was obtained. The solution was then passed through a silica gel column (n-hexane:ethyl acetate = 40:1) to obtain product S7. The yields and ee values were as follows: cat.1: 16.5 g, 60% yield, 57.6% ee; cat.2: 15.4 g, 56% yield, 54.5% ee; cat.3: 13.8 g. 50% yield, 55.9% ee; cat.4: 20.7g, 75% yield, 51.4% ee; cat.5: 25.1g, 91% yield, 82.4% ee; cat.6: 24.5g, 89% yield, 76.4% ee; cat.7: 23.7g, 86% yield, 66.7% ee.
[0054] Example 6:
[0055] Under N2 protection, at room temperature, 30.6 g of S7 (approximately 62.0 mmol) was dissolved in 200 mL of ultra-dry tetrahydrofuran and stirred. 43.5 mL of ethyl magnesium chloride (1.4 eq. 86.8 mmol) in n-hexane was added to a constant-pressure dropping funnel for later use. At 0 °C, under N2 protection, the ethyl magnesium bromide solution in the prepared constant-pressure dropping funnel was slowly added dropwise to the existing solution over approximately 15 minutes. The mixture was stirred at room temperature, and the reaction was monitored by GC until S7 was completely converted, approximately 2.5 h. A bottle of calcium chloride (500 g) was added. Subsequently, at 28 °C, CO2 was filtered through a calcium chloride column and then introduced into the reaction solution. The reaction was monitored by GC. Samples were taken and the pH was adjusted to 1 with dilute hydrochloric acid. After filtration through a filter membrane, GC monitoring was performed. If no change was observed between two injections, the reaction was considered complete, approximately 3 hours later. At 0°C, under stirring, dilute hydrochloric acid was added to quench the reaction until no more bubbles were generated. 100 mL of ethyl acetate and 200 mL of saturated saline solution were added, and the mixture was extracted and separated. The organic phase was collected, and the aqueous phase was extracted again with ethyl acetate. All organic phases were then combined and washed three times with saturated saline solution (100 mL each time). The mixture was dried over anhydrous sodium sulfate to obtain approximately 500 mL of crude S8 in ethyl acetate solution. The crude S8 ethyl acetate solution was then evaporated to silica gel to a fine, slurry-like consistency. The solution was passed through a silica gel column (first washing impurities with n-hexane:ethyl acetate = 10:1, then retrieving the product with n-hexane:ethyl acetate = 2:1) to obtain 23.0 g of product S8 (50 mmol), 81% yield, ee value 88%.
[0056] The obtained S8 was placed in an 80℃ oil bath and dissolved in EA (50 mL). Hexane (400 mL) was added, and the mixture was allowed to stand overnight. The yellow solution was collected by filtration and evaporated to dryness to obtain a yellow solid. The solid was then dissolved completely in DCM at 40℃, evaporated to dryness again, and the solvent was repeatedly removed. The solvent was then removed by pumping out the solid with an oil pump to obtain 18.4 g of S8 (40 mmol), 80% yield, ee value 98.2% (chromatographic conditions: instrument: Agilent 1260; column: CHIRALPAK IH 4.6×250 mm 5 μm; mobile phase: A: hexane, B: isopropanol; gradient: A 95%, B 5%; flow rate: 1.0 mL / min; column temperature: 30℃; time: 20 mins; injection volume: 5 μL; detector wavelength: UV 210 nm; sample concentration: 0.5 mg / mL), purity >99%. 1 19F NMR (376MHz, Chloroform-d) δ-79.4 (s, 3F).
[0057] Example 7
[0058] At 20°C (room temperature), quinine (25.4 g, 78.3 mmol) was added to a 500 mL three-necked round-bottom flask. Under N2 protection, 260 mL of acetone was added to dissolve and stir. The corresponding arylbenzyl bromide (81.4 mmol) was added, and the mixture was transferred to a 60°C oil bath and heated under reflux for 4-6 h. The solution changed from a milky white turbidity to an orange-red clear solution. The reaction was continued at 20°C with stirring for 16 h. Then, the mixture was transferred to a 500 mL single-necked round-bottom flask and evaporated to dryness using a rotary evaporator. The solid was scraped off the flask, a magnetic stir bar was added, and 300 mL of diethyl ether was added. The mixture was stirred for 30 min, and then 50 mL of acetone was used to dissolve and stir. A 0 mL suction filter funnel was dried under vacuum using a circulating water pump and washed three times with an appropriate amount of diethyl ether to obtain a light brown powder, cat.-1. This powder was transferred to a 250 mL single-necked round-bottom flask and dried under vacuum for later use. The yields were: cat.1: 39.9 g, 98% yield; cat.2: 43.1 g, 99% yield; cat.3: 42.3 g, 99% yield; cat.4: 44.3 g, 95% yield; cat.5: 45.6 g, 99.4% yield; cat.6: 45.2 g, 95% yield; cat.7: 49.2 g, 99.5% yield.
[0059] cat.1 1H NMR(400MHz,Chloroform-d)δ8.58(d,J=4.6Hz,1H),8.19–8.16(m,2H),7.83(d,J=9.2Hz,1H),7.62(d,J=4.7Hz,1H),7.59(d,J=8.1Hz,1H ),7.40(t,J=7.8Hz,1H),7.23-7.21(m,1H),7.16-7.13(m,1H),6.52(d,J=5.9Hz,1H),6.29(d,J=6.3Hz,1H),5.95(d,J=12.0Hz,1H),5.55- 5.46(m,1H),5.14(d,J=11.9Hz,1H),5.06(d,J=17.2Hz,1H),4.83(d,J=11.0Hz,1H),4.74(d,J=11.7Hz,1H),4.06-3.98(m,2H),3.90(s,3 H),3.23(t,J=11.7Hz,1H),2.94–2.88(m,1H),2.58(s,1H),2.48(s,1H),2.21-2.12(m,2H),1.93(d,J=3.0Hz,1H),1.46(t,J=11.9Hz,1H).
[0060] cat.2 1H NMR(400MHz,Chloroform-d)δ8.71(d,J=4.6Hz,1H),8.05(d,J=9.1Hz,1H),7.77(d,J=45Hz 1H)743–732(m 2H)699(d J=22Hz 2H)669(s 1H)665–654(m1H)646(t J=2.1 Hz,1H),5.99(d,J=11.8 Hz,1H),5.73–5.60(m,1H),5.20–5.07(m,2H),5.07–5.00(m,1H),4.70(d,J=11.7 Hz,1H),4.00(s,3H),3.77(s,7H),3.40(s,1H),3.27–3.15(m,1H),2.63(s,1H),2.42–2.26(m,2H),2.06(d,J=3.9 Hz,1H),1.80(d,J=12.3 Hz,1H),1.63(t,J=12.3 Hz,1H).
[0061] cat.3 1H NMR(400 MHz,DMSO-d6)δ8.85(d,J=4.5 Hz,1H),8.53(d,J=8.6 Hz,1H),8.20(d,J=8.2 Hz,1H),8.13–8.09(m,1H),8.06–8.03(m,1H),8.02–7.98(m,1H),7.82(d,J=4.5 Hz,1H),7.76–7.70(m,2H),7.68–7.63(m,1H),7.54–7.49(m,2H),6.84(d,J=4.1 Hz,1H),6.78(d,J=4.3Hz,1H),5.93(d,J=13.1 Hz,1H),5.79–5.68(m,1H),5.16(d,J=13.0 Hz,1H),5.07–4.97(m,2H),4.37(t,J=12.4 Hz,1H),4.25(dd,J=10.9,6.3 Hz,1H),4.02(s,3H),3.86–3.79(m,1H),3.28–
[0062] 3.16(m,2H),2.64–2.55(m,1H),2.26(d,J=14.7 Hz,1H),2.22-2.13(m,1H),2.00–1.95(m,1H),1.77(t,J=12.2 Hz,1H),1.50-1.42(m,1H).
[0063] cat.4 1H NMR(400 MHz,Chloroform-d)δ9.13(d,J=9.1 Hz,1H),8.56(d,J=4.6Hz,1H),8.51(s,1H),8.47(d,J=9.0 Hz,1H),8.03–7.97(m,2H),7.96–7.91(m,2H),7.77–7.71(m,2H),7.59–7.55(m,1H),7.45(t,J=7.5 Hz,2H),7.31–7.27(m,1H),7.18–7.07(m,2H),6.88(d,J=13.8 Hz,1H),5.97(d,J=13.9 Hz,1H),5.60–5.51(m,1H),5.10(t,J=11.9 Hz,1H),4.94(d,J=10.4 Hz,1H),4.88(d,J=17.1 Hz,1H),4.38(t,J=8.8 Hz,1H),3.99(s,3H),2.94–2.86(m,1H),2.71–2.65(m,1H),2.33–2.24(m,2H),2.21–2.16(m,1H),1.92–1.86(m,1H),1.56–1.45(m,2H).
[0064] cat.5 1H NMR(400 MHz,Chloroform-d)δ8.72(d,J=4.7 Hz,1H),8.02(d,J=9.3Hz,1H),7.82(d,J=4.8 Hz,1H),7.36–7.31(m,1H),7.25–7.22(m,1H),6.77(s,1H),6.59(s,1H),5.99(d,J=13.5 Hz,1H),5.57–5.48(m,1H),5.03–5.00(m,1H),4.98(s,1H),4.74(d,J=13.5 Hz,1H),4.70–4.61(m,1H),3.99(s,3H),3.95–3.88(m,1H),3.81(t,J=9.1Hz,1H),3.72–3.63(m,1H),3.14(d,J=12.3 Hz,1H),2.80(s,2H),2.22–2.18(m,1H),2.04–1.94(m,2H),1.39(t,J=12.1 Hz,1H);19F NMR(376MHz,Chloroform-d)δ-134.3(s,1F),-147.3(d,J=21.8 Hz,2F),-158.6–158.8(m,2F).
[0065] cat.6 1H NMR(400 MHz,Chloroform-d)δ8.71(d,J=4.6 Hz,1H),8.06(d,J=9.2Hz,1H),7.62(d,J=4.6 Hz,1H),7.55(d,J=1.8 Hz,1H),7.53-7.45(m,2H),7.41 -7.34(m,1H),6.82-6.74(m,1H),6.67(d,J=7.2 Hz,1H),5.99(d,J=12.3 Hz,1H),5.77-5.61(m,1H),5.20(t,J=11.9 Hz,1H),5.15-5.05(m,2H),4.79(d,J=12.2 Hz,1H),4.04(s,3H),3.84-3.66(m,2H),3.35-3.13(m,2H),2.76-2.65(m,1H),2.50-2.34(m,2H),1.88 -1.67(m,2H),1.25(s,18H).
[0066] cat.7 1H NMR(400 MHz,Chloroform-d)δ8.61(s,2H),8.59(d,J=4.6 Hz,1H),7.92(s,1H),7.85(d,J=9.2 Hz,1H),7.63(d,J=4.6 Hz,1H),7.18–7.12(m,1H),6.60(s,1H),6.35(s,1H),6.19(d,J=12.0Hz,1H),5.66–5.56(m,1H),5.45(d,J=11.9 Hz,1H),5.20–5.13(m,1H),4.99–4.89(m,2H),4.32–4.23(m1H)4.15(tJ=8.8Hz1H)3.90(s3H)3.27(tJ=11.7Hz1H)3.00–2.91(m1H)2.60–2.53(m,2H),2.34–2.20(m,2H),2.01(q,J=3.2 Hz,1H),1.81–1.72(m,1H);19F NMR(376 MHz,Chloroform-d)δ-62.7(s,6F).
Claims
1. A method for preparing an S7 compound, characterized in that, Prepared by reacting S6 compound with hydroxylamine in the presence of a catalyst. , Wherein, R1 is Cl; The catalyst has the following structural formula: ; The reaction temperature in step 5 is from -20°C to room temperature; The catalyst was prepared from arylbenzyl bromide and a quinine compound. , Wherein, the Ar group is ; The preparation of the S6 compound includes the following steps: Compound S1 was acylated to prepare compound S2. , Compound S3 was reacted with Grignard to prepare compound S4. , Compound S4 was further reacted to prepare compound S5. , Compound S5 reacts with compound S2 to prepare compound S6. , Where R1 is Cl.
2. The preparation method according to claim 1, characterized in that, Dibromoethane needs to be added in step 2.
Citation Information
Patent Citations
Preparation method of isoxazoline insecticide
CN112457267A
Organic compounds
WO2010070068A2
Cosmetic composition containing inorganic particles for blocking blue light
WO2020091217A1
Process for lotilaner intermediate
WO2022016490A1
Process for making an isoxazoline compound and intermediate thereof
WO2022020585A1
